Sign Up to like & get
recommendations!
0
Published in 2017 at "European Journal of Neurology"
DOI: 10.1111/ene.13189
Abstract: A single, oral dose of 3 mg/day tacrolimus, approved for myasthenia gravis (MG) treatment in Japan, was shown to reduce steroid dose and antiâacetylcholine receptor (AChR) antibody titers as well as to improve MG symptoms.…
read more here.
Keywords:
tacrolimus concentration;
treatment;
gravis treatment;
myasthenia gravis ... See more keywords